16 research outputs found
Results from the multivariable regression model evaluating the association between the inverse of carotid Intima Media Thickening (c-IMT) and various explanatory factors.
<p>CI = Confidence Interval. The final sample included 196 patients.</p
Results from the Cox proportional hazards regression analyses predicting time to vascular events.
<p>Results from the Cox proportional hazards regression analyses predicting time to vascular events.</p
Kaplan-Meier estimates of time to vascular events by alexithymia (TAS-20 score ≥50 versus TAS-20 score <50).
<p>Kaplan-Meier estimates of time to vascular events by alexithymia (TAS-20 score ≥50 versus TAS-20 score <50).</p
Clinical, behavioral and socio-demographic characteristics of the final sample (n = 201).
<p>Clinical, behavioral and socio-demographic characteristics of the final sample (n = 201).</p
Characteristics of the sample according to the presence of atherosclerotic plaque (IMT<sub>max</sub> ≥1.5 mm).
*<p>Kruskal-Wallis test for continuous variables; chi-squared test for categorical ones.</p>**<p>59 missing values (21 among those with plaque; 38 among other participants).</p
T-cells activation and proliferation in Immunological Non Responders with and without HAART intensification with MVC.
<div><p><b>A</b>-<b>B</b>. T-cell activation defined as the co-expression of HLA-DR and CD38 on CD4+ and CD8+.</p>
<p><b>C</b>-<b>D</b>. T-cell proliferation defined as the expression of Ki67 on CD4+ and CD8+.</p>
<p>The vertical lines represent median and interquartile ranges (25<sup>th</sup> and 75<sup>th</sup> percentiles).</p></div
Flow chart illustrating the entire study population.
<p>Flow chart illustrating the entire study population.</p
Univariate and multivariate predictors of event (eGFR decline > 5%) in the study population (144 patients).
<p>Univariate and multivariate predictors of event (eGFR decline > 5%) in the study population (144 patients).</p
Number of patients tested throughout mixed models and correlation with eGFR decline at different time-points.
<p>Number of patients tested throughout mixed models and correlation with eGFR decline at different time-points.</p